 |
 |
Product
Information on ViraPhyte™
Herb Sourcing
ViraPhyte™ is a concentrate of pre-cooked, powdered herbs that is
dissolved in hot water, and taken as a tea. We have carefully researched
vendors and have found Blue Dragon Herbs, Santa Monica, CA, which uses the
highest quality organic, wild-crafted or minimally processed herbs in China.
Most Blue Dragon Herbs are organically grown or wild-crafted at least 100
km (62 miles) from any industrial manufacturing and 50 km (31 miles) from
any town of more than 1,000 residents. Pesticides, fungicides, herbicides
and chemical fertilizers have never been used on the land. Blue Dragon Herbs
are processed under strict GMP guidelines which meet or exceed Western pharmaceutical
standards. Check http://www.bluedragonchineseherbs.com for more information
on Blue Dragon's herbs.
About the Herb Formula
ViraPhyte™ contains 84% organically grown herbs. All ingredients in
ViraPhyte™ are plant substances. No animal or mineral products are
included. These herbs are commonly used in traditional Chinese herbology,
and are generally considered safe. The herbs selected for the formula were
chosen based on:
1. Traditional Chinese herb properties and Chinese medical treatment concepts.
2. The presentation of HIV as understood through classic Chinese medicine
diagnostic principles.
3. A physiological understanding of how HIV causes immune and gastrointestinal
system damage.
4. Evidence of an herb’s anti-HIV activity from laboratory testing.
5. Western medical research on an herb’s known activity on cellular
and viral factors related to HIV progression.
There is no assurance that using ViraPhyte™ will stabilize or increase
T-cell counts, or lower viral load. From our past and current monitoring
of ViraPhyte™ in volunteers, we have seen T-cell increases and lowering
of HIV viral load. The investigators have also observed stabilization of
T-cells and viral load with good general health. Some participants did not
respond at all. We have seen a patient who for months had a T-cell increase
and viral load decrease, but who eventually began to lose T-cells, but maintained
a low viral load. During the use of ViraPhyte™, the patient also saw
improvements of several other blood marker including: CD4/CD8 ratio, WBC,
RBC, platelets, triglycerides, AST, ALT, absolute neutrophils/lymphocytes
and albumin. Subsequently, he stopped the formula due to decreasing T-cells,
and started medications with excellent results.
We have been testing and refining this formula since 2002; our first pilot
study was in 2003-2004. The formula has been well-tolerated, with very few
side effects which were easily alleviated by decreasing the dose. We ask
patients to start the formula slowly to avoid any rapid detoxification reaction
to the herbs. Many patients have comfortably been using the formula for
up to one year without any strong side effects.
Occasional complaints from using ViraPhyte™ include: loose stools
and stomach upset or reflux. Reducing the dosage typically resolves this.
Note: the investigators have not determined an optimal dose, and ideally
the dose should be based on body weight.
The use of ViraPhyte™ for HIV infection is experimental, and its scope
of use is still to be determined. Because many of the formula's herbs are
also traditionally used to address the causes of high cholesterol, triglycerides
and elevated liver enzymes, the investigators also hope that the use of
the formula during a break may also help to reverse certain ARV side effects.
Precautions
Recent data suggest that treatment interruptions (breaks) from antiretrovirals
may have attendant risks. However, other studies suggest methods to minimize
these risks. The potential risk of stopping ARV drugs may be significant;
if you are on ARV medications, you should discuss the possibility of these
risks with your primary care physician. The investigators are prepared to
discuss questions about this decision. Patients with less than 250 T-cells
are nearing risk of opportunistic infections. As the anti-HIV effects ViraPhyte™
are presently not known, we strongly advise patients with less than 250
T-cells to start or re-initiate antiretroviral therapy. If you wish to start
ViraPhyte™ with less than 250 T-cells, we require a signed statement
stating that you have been counseled by us to speak with your doctor about
starting ARV therapy. |
 |